Graves' disease
RecruitingStudy of IMVT-1402 Treatment for Adults with Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Poland- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations
Back to Poland184 clinical trials in Kielce, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, breast cancer, and lymphoma treatments. Studies evaluate novel drug combinations and targeted therapies for improved patient outcomes.
Advanced research includes studies on prostate cancer and neuroendocrine tumors using cutting-edge therapeutic approaches.
Groundbreaking research in multiple sclerosis and Alzheimer's disease. Trials evaluate new treatments for both relapsing forms of MS and psychosis associated with Alzheimer's.
Focus on developing innovative therapeutic solutions for complex neurological conditions.
Comprehensive research addressing hypertension, cardiovascular disease, and metabolic disorders. Studies investigate preventive approaches and novel treatment combinations.
Innovative trials exploring new therapeutic strategies for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.